CLL was initially targeted with CAR T‐cell therapy18; however, the effective application of CAR T‐cell treatment in CLL has not been fully realized even with ongoing clinical studies evaluating anti‐CD19 CAR T‐cell therapy.19, 20. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.